Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
暂无分享,去创建一个
J. Trejo | Yu Ding | Tiffany K Ricks | Anuradha Gullapalli | D. Morris | Tiffany K. Ricks | Breann L. Wolfe | Dionne Morris
[1] A. Agarwal,et al. PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.
[2] J. Trejo,et al. Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking , 2005, Molecular Pharmacology.
[3] R. Lefkowitz,et al. Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2* , 2004, Journal of Biological Chemistry.
[4] S. Coughlin,et al. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. , 2004, Blood.
[5] U. Pendurthi,et al. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. , 2004, Blood.
[6] C. Der,et al. Persistent Signaling by Dysregulated Thrombin Receptor Trafficking Promotes Breast Carcinoma Cell Invasion , 2004, Molecular and Cellular Biology.
[7] Xiaofeng Jiang,et al. Formation of tissue factor–factor VIIa–factor Xa complex promotes cellular signaling and migration of human breast cancer cells , 2004, Journal of thrombosis and haemostasis : JTH.
[8] W. Ruf,et al. Specificity of coagulation factor signaling , 2003, Journal of thrombosis and haemostasis : JTH.
[9] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[10] T. Peretz,et al. Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[11] M. Salis,et al. Protease-Activated Receptor-2 Stimulates Angiogenesis and Accelerates Hemodynamic Recovery in a Mouse Model of Hindlimb Ischemia , 2002, Circulation research.
[12] W. Ruf,et al. Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.
[13] S. Coughlin,et al. Genetic Evidence That Protease-activated Receptors Mediate Factor Xa Signaling in Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[14] T. Kohout,et al. β-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation* , 2002, The Journal of Biological Chemistry.
[15] F. Foss,et al. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. , 2001, Cancer research.
[16] M. D'Andrea,et al. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. , 2001, The American journal of pathology.
[17] W Ruf,et al. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. , 2001, Blood.
[18] T. Bugge,et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. , 2000, Blood.
[19] S. Coughlin,et al. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Mullins,et al. β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.
[21] C. Costello,et al. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. , 1999, Biochemistry.
[22] B. Pentecost,et al. Role of thrombin receptor in breast cancer invasiveness , 1999, British Journal of Cancer.
[23] K. Takeshita,et al. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. , 1998, Blood.
[24] Reuven Reich,et al. Thrombin receptor overexpression in malignant and physiological invasion processes , 1998, Nature Medicine.
[25] W. Ruf,et al. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. , 1998, The Journal of clinical investigation.
[26] Stefan Offermanns,et al. Defective platelet activation in Gαq-deficient mice , 1997, Nature.
[27] D. Payan,et al. Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* , 1996, The Journal of Biological Chemistry.
[28] Robert Kay,et al. Expression cloning of oncogenes by retroviral transfer of cDNA libraries , 1995, Molecular and cellular biology.
[29] H. Dvorak,et al. Vascular Permeability Factor, Fibrin, and the Pathogenesis of Tumor Stroma Formation a , 1992, Annals of the New York Academy of Sciences.
[30] M. Prins,et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. , 1992, The New England journal of medicine.
[31] S. Karpatkin,et al. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. , 1992, Cancer research.
[32] V. Wheaton,et al. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. , 1992, The Journal of clinical investigation.
[33] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.
[34] K. Mann,et al. Tumor cell generation of thrombin via functional prothrombinase assembly. , 1985, Cancer research.